pharma imports

India’s pharmaceutical & software entrepreneurs show how economic strength matters in disrupted geopolitics. We should build such partnerships across the economy to navigate global headwinds

German researchers are making waves with a cutting-edge 'Trojan horse' obesity drug that has eclipsed current frontrunners in trials with mice. The innovative formula decreases appetite and weight significantly while also enhancing blood sugar levels and insulin sensitivity. Utilizing hormone mimics for precise cellular targeting, this approach minimizes unwanted side effects and presents a multifaceted method for combating obesity.

Roche’s subcutaneous Tecentriq can be given in about seven minutes, cutting infusion time dramatically. But its impact in India will depend on patient selection, local post-marketing data, hospital readiness and whether a costly immunotherapy can become accessible beyond large private cancer centres

Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs

Admissions are open for IISER Tirupati one-year Professional Master’s Programmes for 2026-2027 under Biological Data Science (BioDS) and Data Science and Artificial Intelligence (DS-AI). Offered in online mode, programmes target graduates and working professionals from science, technology and allied fields. Curriculum combines theoretical and applied learning with hands-on projects using real datasets. Eligibility includes specified undergraduate or postgraduate qualifications. aim to prepare industry-ready professionals for roles in data science, AI, biotechnology and life sciences sectors.

Country needs time to build up domestic capacities, till then reduce dependence on those ‘perfect’ imports

JPMorgan has shifted its stance on Indian equities to neutral, citing high valuations and geopolitical uncertainties. The brokerage warns of a potential 15% Nifty 50 decline in a worst-case scenario, impacting earnings due to energy supply risks. While the long-term outlook remains robust, near-term caution is advised, with other emerging markets potentially offering better opportunities.

Persistent Systems aims for $2 billion revenue by FY27. CEO Sandeep Kalra sees AI creating new opportunities, not just reducing costs. The company reported steady March quarter revenue. Kalra highlighted a platform-led approach and robust growth in top accounts. Persistent is investing in capabilities for long-term growth and adaptability.

What sets Qdenga apart is that it can be administered regardless of a prior infection. A phased rollout could take place as early as this year

A prolonged Middle East conflict could significantly impact India's exports, both regionally and globally, due to supply chain disruptions, Commerce Secretary Rajesh Agrawal warned. He urged the pharmaceutical industry to reduce reliance on imported raw materials and build stronger domestic capacities to mitigate these risks and ensure continued growth in the sector.

The US has imposed up to 100% tariffs on patented drugs and certain metals, aiming to boost domestic manufacturing. While India's generic drug exports are largely exempt, firms producing branded medicines or inputs for patented drugs may face pressure. Developed nations are expected to bear the brunt of these new measures.

Homes Fully Served, Biz Demand 80%

A young doctor resigned on her first day at a private hospital, alleging a system prioritizing profit over patient care. She claimed unnecessary admissions and prolonged ICU stays were encouraged to inflate bills. Her viral video has ignited widespread debate on healthcare ethics and the profit-driven nature of some private hospitals.

It’s the start of a new financial year, and if you are wondering where to put your money - this article has you covered. We asked five experts what they think is the right portfolio strategy for investors at the current juncture.